Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
EMD Serono
EMD Serono
Seagen Inc.
Seagen Inc.
Genentech, Inc.
National Cancer Institute (NCI)
AbbVie
Jazz Pharmaceuticals
Exscientia AI Limited
Alliance for Clinical Trials in Oncology
AstraZeneca
Aulos Bioscience, Inc.
AstraZeneca
University of California, Irvine
Neonc Technologies, Inc.
ViroMissile, Inc.
Arvinas Inc.
Tizona Therapeutics, Inc
Brigham and Women's Hospital
Baylor College of Medicine
MacroGenics
Daiichi Sankyo
OneCarbon
University of Nebraska
Zhejiang University
Adela, Inc
Perspective Therapeutics
Innate Pharma
Dren Bio
Var2 Pharmaceuticals
Tanabe Pharma America, Inc.
Massive Bio, Inc.
LigaChem Biosciences, Inc.
Washington University School of Medicine
Nurix Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Apollomics Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Columbia University
Merus B.V.
Pack Health
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Taiho Pharmaceutical Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Cancer Research UK
Zhujiang Hospital
Second Affiliated Hospital of Guangzhou Medical University